Bio developments

© Getty Images

Nature Immunology spotlights Alchemab's cancer therapy potential

By Isabel Cameron

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, has published a peer-reviewed article titled "Predictability of B cell clonal persistence and immunosurveillance in breast...

© Getty Images

What innovations are reshaping the pharma services sector?

By Isabel Cameron

We sat down with Jay Ferguson, director at Houlihan Lokey's Healthcare Group, to discuss why he views the pharma services sector as a highly promising investment opportunity. He outlines his prediction that a confluence of tailwinds is set to sustain...

© Getty Images

CPHI North America 2024

Piramal Pharma unveils expanded services and growth vision

By Isabel Cameron

What is ADC specialist Piramal Pharma planning for the upcoming CPHI North America conference? We sat down with chief commercial officer Stuart Needleman to find out what's on the company's agenda.

© Getty Images

CPHI North America 2024

Selkirk Pharma: Adapting to regulatory shifts and market demand

By Isabel Cameron

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.